Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Felder-Puig, R. (2007): [Age-related macular degeneration. Treatment and quality of life]. HTA-Newsletter 53: p. 2.

Wild, C. (2006): [Pegaptanib (Macugen®) for age-related macular degeneration (AMD)]. HTA-Newsletter 46: pp. 3-4.

Wild, C. (2004): [Age-related macular degeneration: An update]. HTA-Newsletter 26: pp. 3-4.

Wild, C. (2001): [Age related macular degeneration. Photodynamic therapy]. HTA-Newsletter 01: p. 3.

Wild, C. and Mathis, S. and Guba, B. and Gartlehner, G. (2008): [Rheopheresis in patients with age-related macular degeneration, sudden hearing loss or tinnitus, diabetes. Systematic review]. Decision Support Document 12.

Wild, C. (2012): Avastin for Age-related Macular-Degeneration. Evidence synthesis after CATT, IVAN, MANTA. Rapid Assessment 005.

Wild, C. and Adlbrecht, C. (2007): [Avastin for age-related macular degeneration]. Rapid Assessment LBI-HTA 02.

Zechmeister, I. (2007): [Age-related macular degeneration (AMD): Diagnostics]. HTA-Newsletter 56: pp. 2-3.